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Abstract
Background: In search for genes predisposing to osteoarthritis (OA), several genome wide scans have provided
evidence for linkage on 2q. In this study we targeted a 470 kb region on 2q11.2 presenting the locus with most
evidence for linkage to severe OA of distal interphalangeal joints (DIP) in our genome wide scan families.
Methods: We genotyped 32 single nucleotide polymorphisms (SNPs) in this 470 kb region comprising six genes
belonging to the interleukin 1 superfamily and monitored for association with individual SNPs and SNP haplotypes
among severe familial hand OA cases (material extended from our previous linkage study; n = 134), unrelated end-
stage bilateral primary knee OA cases (n = 113), and population based controls (n = 436).
Results: Four SNPs in the IL1R1 gene, mapping to a 125 kb LD block, provided evidence for association with hand
OA in family-based and case-control analysis, the strongest association being with SNP rs2287047 (p-value =
0.0009).
Conclusions: This study demonstrates an association between severe hand OA and IL1R1 gene. This gene
represents a highly relevant biological candidate since it encodes protein that is a known modulator of
inflammatory processes associated with joint destruction and resides within a locus providing consistent evidence
for linkage to hand OA. As the observed association did not fully explain the linkage obtained in the previous
study, it is plausible that also other variants in this genome region predispose to hand OA.
Background
Osteoarthritis (OA) is a complex late onset disease char-
acterized by the destruction of joints and it can occur in
one or multiple joint groups as hand and knee OA
often do [1-3]. The most frequent clinical findings in
OA are pain associated with loading and limited range
of motion in the joints at later stages. Typical radio-
graphic findings, narrowing of the intra-articular space
and osteophytes, are considered superior to clinical
manifestations in the diagnostic definition [4]. There is
a strong genetic effect on hand and knee OA, with her-
itability ranging between 39%-65% independent of
known environmental or demographic confounders [5].
Based on a Finnish study [2], the genetic effects seem to
be more prominent in females.
Our genome wide linkage analysis in OA families
identified chromosome 2q11-q21 locus as the major
locus for severe hand OA in Finnish families [6]. The
same locus has been identified in screens of rare multi-
plex pedigrees and sibpairs from more heterogeneous
populations [7,8], and in a large population-based twin
cohort [9]. The 2q11-q21 locus harbours the interleukin
1 (IL-1) gene cluster. The marker providing strongest
evidence for linkage in Finnish distal interphalangeal
joint (DIP) OA families resides within the IL1R1 gene
(LOD score 2.34), and some evidence for a shared hap-
lotype among the affected individuals was observed with
markers D2S2264, IL1R1, D2S373, and D2S1789
(p-value of 0.012) [6]. Further, a handful of association
studies have shown a potential role for interleukin-1
gene family in knee and hip OA [10-12].
In the human genome, IL1R2, IL1R1, IL1RL2, IL1RL1,
IL18R1 and IL18RAP are located in a 470 kb cluster on
2q11. Genes coding for most other IL-1 ligands are also
clustered on chromosome 2 [13]. IL-1 is a pleiotropic
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cytokine involved in the initiation of inflammatory and
immune responses. Using gene names also for their pro-
tein products, a complex of IL-1 (IL1A or IL1B), IL1RI
and IL1RAP are needed for signal transduction. There
are other interleukin ligand-receptor complexes leading
to NF-B activation too [14-16]. Therapeutic effect of
IL-1 receptor antagonist (IL1RN) gene transfer has been
confirmed in different experimental models of OA [17].
Our aim was to study more closely the 2q11-q21
locus, major locus for severe hand OA in our previous
study, using SNPs and SNP haplotypes in extended
hand OA families (including siblings with a severe, radi-
ologically defined bilateral DIP OA used in our genome
scan [6]), and in a set of severe primary bilateral knee
OA patients. We targeted a 470 kb region in chromo-
some 2q11.2 by genotyping 32 SNP markers in total of
220 DNA samples from individuals affected with OA
and in 436 population controls.
Methods
Subjects
Our hand OA material was based on the set of radiolo-
gically verified severe DIP OA families from our pre-
vious study described in more detail in Leppävuori et al.
[6] and summarised in Table 1. DNA samples of 86
severe radiologically verified bilateral DIP OA cases
were available from our previous study [6]. A radiologist
had graded the osteoarthritic changes in the hand x-rays
for DIP, PIP, MCP joints (according to [18]). Data for
reported height and weight were available. Subjects with
rheumatoid arthritis (RA) were excluded. Inclusion cri-
teria were 3rd or 4th degree Kellgren and Lawrence
(K/L) radiographic OA in DIP joints (bilateral) and a posi-
tive family history of OA, with at least one sibling with
DIP OA. The other siblings were included as affected indi-
viduals if they had a K/L score ≥ 2 in DIP joints.
Additionally, 21 unaffected family members derived from
40 families were available for this study. Study set was
further extended by 17 radiologically verified severe DIP
OA cases collected from the ORTON Orthopaedic Hospi-
tal (Helsinki, Finland) with the same radiographic criteria
as used in selecting the index cases in initial material
(Table 1) and also 4 affected siblings. The average age at
grading of hand X-rays was 62 years (SD 9 y). For more
about diagnostics and epidemiology of hand OA, see
Haara et al. [19].
To collect knee OA material, we reviewed case reports
of 852 patients visiting ORTON Orthopaedic Hospital
between 1994-2001 having knee OA and identified 220
patients with primary bilateral knee OA severe enough
to fulfill the criteria for knee arthroplasty: pain, walking
disability and radiologically at least stage 3/4 osteoar-
thritic changes according to Kellgren and Lawrence clas-
sification [20]. Of the 220 patients, we reached 113
subjects, who had not had a major knee trauma and
volunteered to participate by providing a DNA sample
(Table 1). Knee OA patients’ pain or other OA symp-
toms began at a mean age of 52 y (SD 12 y), and mean
age at first arthroplasty was 67 y (SD 8). 28 patients had
physician-diagnosed hand OA and were also included in
the hand OA material to increase statistical power.
The control subjects (n = 436, aged 35-70) were
selected from the Finnish twin cohort [21]. Approxi-
mately half of this control material (n = 210) was selected
from the Finnish twin cohort [21] with inclusion criteria
of born in 1938-1941, responded to a questionnaire in
1996-1997, did not have diagnosis of OA and gave DNA
samples for analyses. One twin from each twin pair was
included in the control group if neither twin had physi-
cian diagnosed OA or RA, and neither twin reported that
their mother, father, co-twin or any other sibling had OA
or RA. The remaining half (n = 226) of the controls were
subjects of Twin Spine study which is part of the Finnish
twin cohort study. The Twin Spine study consists of 300
male twin pairs selected on the basis of putative risk fac-
tors for low back pain and disc degeneration (not parti-
cularly suffering from either) as described elsewhere
[22,23]. Subjects with a physician-diagnosed OA were
excluded, and only one twin from a pair was included.
The study was approved by the ethics committee of the
Helsinki metropolitan hospital region and all individuals
gave their informed consent.
Methods and statistical analyses
A set of 49 SNPs with a minimum heterozygosity of 0.2
in the Caucasian population were selected from Seat-
tleSNP [24] and Snpper CHIP Bioinformatics Tools [25]
databases to cover the 470 kb target region with
approximately 10-kb SNP spacing (Fig. 1). These SNPs
were genotyped using the MassARRAY® system
Table 1 The number of cases and controls according to
case definition and sample provenance
Number of subjects
Total Male Female
Hand OA material 168a 36 132
44 families with ≥ 2 DIP OA casesb 116 22 94
4 families with 1 DIP OA caseb 15 5 10
Additional radiologically verified DIP OA casesb 9 4 5
Physician diagnosed hand OA casesc 28 5 23
Knee OA materialb 113 27 86
Controls 436 277 159
Total 689 335 354
a = The total number of affected individuals was 134 of which 85 were
unrelated
b = Radiologically verified OA cases
c = Physician diagnosed hand OA; this group is also a part of radiological
knee OA material
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(Sequenom, San Diego, CA, USA) as recommended by
the manufacturer with additional quality assessment
steps described in more detail in Silander et al. [26].
The genotyping was done in multiplexes of 1-5 SNPs
using hME assays in 384-well plates. Each SNP multi-
plex was validated by genotyping 81 trio samples (i.e. 27
families with two parents and a child) to control for
Mendelian incompatibilities using Pedcheck 1.1 program
[27]. Each 384-well plate contained 8 duplicate samples
and 8 non-template wells for quality assessment. If the
genotypes could not be reliably called, if there were
unexplainable errors in Mendelian inheritance or
between duplicate samples, or genotypes in the non-
template wells, SNP was excluded from the study.
Further, only SNPs with call rate of over 90% were
included. A total of 32 SNP passed the preset quality
criteria and were included in the further analysis. All
included SNPs showed HW p-values of more than 0.1.
Figure 1 SNP selection based on the results of genome wide scan by Leppävuori et al. [6]. Pairwise dominant Zmax values (columns);
-log10 P values measuring the maximum number of genes among affecteds IBD to any founder gene (continuous line); selected SNPs markers
for this study (arrows); association to hand OA (p-value < 0.05) (star).
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Additionally using a microarray based allele specific
primer extension method [28], we genotyped eight SNPs
in more studied area in chromosome 2q harbouring the
TRAP1, IL1A, IL1B, IL1F5 and IL1RN genes (rs1030878,
rs2071375, rs1800587 (SNP genotyped approximately in
half of the controls, n = 169), rs1143634, rs1530551,
rs2234677, rs315952, and rs9005) three of which were
previously analysed by Smith and colleagues [29]. In this
additional analysis we lacked 67 individuals (one hand
OA case, four unaffected hand OA family members, 21
knee OA cases and 41 controls).
Deviation from the Hardy-Weinberg equilibrium was
tested using Pearson’s c2 test in the control sample. For
hand OA families, Pedcheck 1.1 [27] was used to rule
out Mendelian errors. The degree of pairwise linkage
disequilibrium (LD) was calculated for each pair of
SNPs in control samples using the Haploview program
[30]. Both r2 and D’ measures of LD were studied.
Then, evidence for association was evaluated in hand
OA and knee OA subgroups using the Pseudomarker
0.9.7 beta program which can utilize the information
from family and case-control settings [31]. We moni-
tored for LD with the disease assuming linkage. Results
were confirmed by traditional c2 analysis (including only
an index case of each hand OA family) or by Fisher’s
test when less than five individuals were carrying the
same genotype. The Pseudomarker analysis was per-
formed additionally for females only in both disease
groups. The number of males was too small in both
case groups for separate analysis.
To evaluate the power in negative findings for knee
OA group, we calculated the amount of cases required
to have 90% power to detect similar association as with
the hand OA group and the power with 113 cases using
the Genetic Power Calculator [32]. The SNPSpD
method [33] with modifications by Li and Ji [34] was
used to calculate the p-value threshold for 5% signifi-
cance [35].
Next using the Haploview program [30], we performed
haplotype association test in the area that showed the
strongest evidence for association with individual SNPs
located in a single LD block measured by r2, covering
the IL1R1 gene (rs1465325, rs956730, rs3917225,
rs2287047, rs3771200) (index case per family in hand
OA group). We further estimated haplotypes for each
subject individually using the Phase2 program [36,37]
for calculating odds ratios (OR) for associated haplo-
types (index case per family in hand OA group). A mini-
mum probability of ≥ 0.60 was requested for the
haplotypes, and alleles with a frequency of over 0.05 in
the control sample were each analyzed separately and
the less common haplotype alleles were grouped
together. Hardy-Weinberg equilibrium was calculated
for tested haplotypes to confirm the correctness of the
haplotype allele distribution. For further information on
the haplotype association in the hand OA group, we
conducted haplotype association test in the associated
area for SNPs in LD measured by D’ solid spine of LD
(rs1465325, rs956730, rs3917225, rs2287047, rs3771200,
rs2241132, rs870684, rs1922290 and rs1922295) using
the Haploview program [30].
Finally, to study the linkage between hand OA and
SNPs showing the strongest association with hand OA,
the Pseudomarker program was used. Then, to assess if
affected individuals with a certain genotype contribute
more than expected to original linkage in the region, we
used the genotype-IBD Sharing Test (GIST) software
package [38,39]. Analysis was performed with the
families used in the original genome-wide linkage scan
and also included in this study (23 families). We used
genotype data for SNPs showing the most significant
association and single point NPL scores for the original
“IL1R1” microsatellite marker for each family obtained
from the Merlin program [40,41].
Results
A set of 32 SNPs mapping within a 470 kb region on
2q11.2 presenting the locus with most evidence for link-
age to severe hand OA in our previous genome wide
scan families (Fig. 1) was genotyped in severe hand OA
cases (n = 134), end-stage bilateral primary knee OA
cases (n = 113) and controls (n = 436) (Table 1).
According to SNPSpD, the effective number of indepen-
dent SNP loci was 23.9 thus the experiment-wide signif-
icance threshold 0.0021 was required to keep the type I
error rate at 5%. The p-values of the association analysis
are presented in Table 2 as non-corrected. Out of 32
SNPs, four SNPs in IL1R1 gene in 125 kb area showed
some evidence for association to hand OA (p-values <
0.05), in a family-based association analysis using the
Pseudomarker program and/or in the case-control ana-
lysis (Table 2). Association with severe hand OA was
concentrated in one LD block (r2 > 0.34, D’ > 0.94) har-
boring the area of long promoter and the coding region
of gene IL1R1 (Fig. 2). It is notable, that association of
the SNP rs2287047 to severe hand OA (odds ratio (OR)
for genotypes AA vs. GG = 0.16, 95% confidence inter-
val (CI) = 0.06 to 0.45; OR for genotypes AA vs. AG =
0.26, 95% CI = 0.09 to 0.73; protective A allele being the
minor allele; p = 0.0009 dominant mode of inheritance)
remained statistically significant after correction for
multiple testing. This SNP is located in intron 1 of the
IL1R1 gene. Association analysis using only female hand
OA subjects provided comparable results (best p-value
0.0045 for SNP rs2287047, dominant model).
One SNP (rs956730) in the same LD block showed
nominal association in knee OA material (p = 0.045,
minor allele frequency = 0.324) and further analysis
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using female knee OA subjects only provided some evi-
dence for association with SNPs in the same LD block
(r2 = 0.17, D’ = 0.90) (Fig. 3) mapping within the
IL1RL2 gene (p-values 0.0098, 0.012 and 0.012 for SNPs
rs870684, rs1922290 and rs1922295, respectively; domi-
nant model). However, none of the associations were
statistically significant after correcting for multiple
testing.
At least 503 knee OA cases would have been required
to have 90% power to detect association at the level of
p < 0.001 for SNP rs2287047 when assuming a similar
effect size as observed in the family-based severe hand
OA (OR 22 vs. 11 = 0.16), whereas the power to detect
association with the 113 knee OA cases was 12%. Most
probably the effect size of the studied SNP (rs2287047)
observed here is an over-estimate and if assuming an
effect size typically seen in complex diseases (expected
risk ratios (RRs) for a single SNP closer to 1.2 and 1.15,
for AA and Aa, respectively), approximately 4000 cases
would have been needed for detecting the association
with 80% power (allele frequency of 0.75 and prevalence
of 0.1) [32].
We were not able to detect association (Pseudomarker
and Pearson’s c2 tests) with any of the SNPs in the pre-
viously more intensively studied area (TRAP1, IL1A,
IL1B, IL1F5, IL1RN) (p > 0.14). Also, opposite to find-
ings by Smith et al.[29], we did not find LD between
SNPs in IL1R1 and the locus containing IL1A, IL1B, and
IL1RN in our study material (r2 ≤ 0.03, D’<0.54).
To cover most of the allelic variation on the genome
region showing evidence for association to severe hand
OA, we monitored for haplotype association for IL1R1
(rs1465325, rs956730, rs3917225, rs2287047, rs3771200)
in hand and knee OA groups using the Haploview pro-
gram [30] (Table 3). The frequencies of allele 3
(CAAAG) differed between hand OA cases (0.104) and
controls (0.188) (p-value 0.008). SNP rs1465325 (OR CT
vs. TT = 0.59, CI = 0.45 to 0.78; p = 0.022) tagged the
protective allele. The protective A allele of SNP
rs2287047 for hand OA was observed in two allelic
backgrounds, on allelic haplotypes 3 and 5. Also, fre-
quencies of the rare haplotype 5 (TAAAG) differed
between knee OA cases (0.103) and controls (0.053)
(p-value 0.004), but the haplotype 5 was the predisposing
haplotype.
Next, we estimated individual haplotypes with the
Phase2 program [36,37], to calculate an odds ratio for
the associated allelic haplotypes on basis of one allele
versus all other alleles. We were able to estimate haplo-
types fulfilling the preset criteria (probability ≥ 0.60) for
96.5% of the hand OA samples, 95.6% of the knee OA
samples and 100% of the controls, and the frequencies
of the estimated haplotypes were comparable to ones
provided by Haploview. When comparing the hand OA
material and controls, the associated protective allele 3
(CAAAG) provided an odds ratio of 0.54 (OR 3X vs.
XX, 95% CI = 0.41 to 0.72) and the rare allele 5
(TAAAG) an odds ratio of 1.81 in the knee OA (OR 5X
vs. XX, 95% CI = 1.34 to 2.43) where the X represents
all other alleles combined. We were only able to calcu-
late an odds ratio for one associated allele versus no
associated alleles (3X vs. XX and 5X vs. XX) since there
Table 2 Results of the single SNP association analysis of
a 470 kb region on 2q11.2 in hand OA study sample
Controls Hand OA
p-values
Gene SNP MAF MAF c2 Pseudomarker
I rs740044 0.178 0.155 0.507a 0.517
rs4141134 0.269 0.250 0.635a 0.327
IL1R2 rs719250 0.182 0.177 0.867 0.382
rs3218934 0.406 0.456 0.246 0.086
rs3218984 0.394 0.424 0.472 0.185
II rs1008394 0.394 0.439 0.281 0.083
rs2310173 0.304 0.351 0.226 0.370
IL1R1 rs1465325 0.195 0.119 0.022a 0.005
rs956730 0.260 0.204 0.140a 0.026
rs3917225 0.396 0.309 0.043 0.078
rs2287047 0.249 0.159 0.013a 0.0009b
rs3771200 0.411 0.453 0.312 0.539
IL1RL2 rs2241132 0.158 0.141 0.644a 0.491
rs870684 0.378 0.394 0.690 0.781
rs1922290 0.377 0.420 0.304 0.495
rs1922295 0.379 0.400 0.613 0.696
rs1997502 0.353 0.318 0.375 0.681
rs2302612 0.119 0.157 0.199a 0.505
III rs1558626 0.446 0.488 0.313 0.108
rs1345302 0.447 0.414 0.428 0.205
rs1882510 0.224 0.229 0.919a 0.517
rs1420089 0.154 0.151 1.000a 1.000
IL1RL1 rs1997466 0.476 0.427 0.250 0.385
rs1041973 0.202 0.173 0.458a 0.202
rs12905 0.274 0.235 0.293 0.366
IL18R1 rs2287037 0.383 0.416 0.433 0.461
rs2270298 0.265 0.189 0.081a 0.131
rs1035130 0.277 0.241 0.338 0.453
rs1420096 0.466 0.458 0.868 0.746
IL18RAP rs1420106 0.192 0.200 0.832a 0.454
rs1420100 0.469 0.447 0.599 1.000
rs917997 0.189 0.185 1.000a 0.990
MAF = Minor allele frequency in the sample set
c2 = p-values from Pearson’s c2 analysis of allele difference between cases
and controls
Pseudomarker = p-values of the family-based association analysis with
Pseudomarker (dominant mode of inheritance)
I, II and III = three intergenic regions
a = calculated with Fisher’s test
b = p-value remained statistically significant after correcting for multiple
testing
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were no individuals homozygote for the associated allele
either in the case groups or in the control group. The
effect of allele 5 to knee OA was opposite to the effect
for hand OA, but it is important to note that the allele
5 was rare.
We also performed a haplotype association test by
selecting SNPs in D’ LD with each other (measured by
D’>0.94 for the first and the last SNP in the block; SNPs
rs1465325, rs956730, rs3917225, rs2287047, rs3771200,
rs2241132, rs870684, rs1922290 and rs1922295) in hand
OA group and in controls. Allele CAAAGCTGC corre-
sponding to allele 3 (CAAAG) in the previous test,
showed similar allele frequencies, allele CAAAGCTGC
being more rare in the hand OA cases (0.101) than in
the controls (0.190) (p = 0.0058).
The four SNPs showing some association with hand
OA provided also nominal evidence for linkage in the
families (LOD = 0.640670, p = 0.042930 for rs1465325;
LOD = 1.343799, p = 0.006440 for rs956730; LOD =
0.281669, p = 0.127359 for rs3917225; LOD = 0.841737,
p = 0.024494 for rs2287047). Although all except one
affected individual carried the predisposing common
G-allele of rs2287047, GIST analysis resulted in non-sig-
nificant p-values when using combined model of domi-
nant, recessive and additive models (p = 0.672 for
rs1465325, p = 0.499 for rs956730, p = 0.563 for
rs3917225, p = 0.998 for rs2287047), suggesting that the
SNPs in IL1R1 do not fully explain the originally
observed linkage.
Discussion
This study identifies an association between severe hand
OA and the variants of the IL1R1 gene. The strongest
evidence for association, which remained statistically sig-
nificant after correction for multiple testing, was
observed with SNP (rs2287047) located in the intron 1
of the IL1R1 gene. This gene represents a highly rele-
vant biological candidate gene since it encodes protein
that is a known modulator of inflammatory processes
associated with joint destruction and resides within a
locus providing consistent evidence for linkage to hand
OA. IL1R1 did not show significant single SNP
Figure 2 LD structure and the degree of linkage disequilibrium (r2) for each SNP pair in control sample [30]. SNPs associating to hand
OA (stars) and r2 haplotype block.
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association with knee OA. It is possible that IL1R1 does
not have strong or any affect in knee OA, or the lack of
association for knee OA is due to lack of power in the
analysis. Also the knee OA patients did not have a simi-
lar strong family background for the disease as the hand
OA patients. However, nominal association in the same
D’ LD block in IL1RL2 gene was observed for knee OA
in females. Further, the association between radiological
bilateral DIP OA (K/L at least 2) and IL1R1 and IL1RL2
genes was recently studied also by Solovieva et al. [42]
in study material of 206 cases and 328 controls. None of
the single SNPs (rs1465325, rs956730, rs2287047)
showed association to bilateral DIP OA, but some occu-
pation dependent association was observed with a hap-
lotype covering the IL1R1 and IL1RL2 genes. However,
it is worth of noting that the phenotype utilized in the
study by Solovieva and collaborators is not equivalent to
the phenotype used here (severe bilateral hand OA) and
that approximately 4000 cases would be required to
exclude SNPs with the effect size typically observed in
complex diseases.
There are some limitations in the present study. Based
on the GIST analysis, the observed associations for sin-
gle SNPs in this study does not fully explain the linkage
obtained in the previous study using microsatellite mar-
kers. It is likely that the SNPs associated with hand OA
in this study are not the causative variants but are prob-
ably in LD with the true causative variant(s) located in
the IL1R1 gene region. Furthermore, it is plausible that
allelic variants in several genes within this locus contri-
bute to OA susceptibility, each with a small effect.
Other studies seem to support this hypothesis: The
Figure 3 LD structure and the degree of linkage disequilibrium (D’) for each SNP pair in control sample [30]. SNPs associating to hand
OA (stars) and D’ haplotype block.
Table 3 IL1R1 haplotype frequencies in hand OA patients
and in controls and the p-value for the difference
(one allele versus all other alleles combined) based on
the Haploview program [30]
Allele frequenciesa
No. Allele Controls Hand OAa p-value
1 TGGGA 0.381 0.440 0.147
2 TGGGG 0.218 0.212 0.865
3 CAAAG 0.188 0.104 0.008
4 TGAGG 0.115 0.123 0.772
5 TAAAG 0.053 0.048 0.796
6 others - -
a Only the index case of each hand OA family was included
Only haplotypes with frequency of over 0.05 in control sample are shown. The
SNPs used to estimate the haplotypes were rs1465325, rs956730, rs3917225,
rs2287047 and rs3771200, respectively.
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interleukin 1 gene family has recently been a widely stu-
died target in osteoarthritis [8,10-12,29,43-46], partly
due to several genome wide scans demonstrating linkage
to this region [6-8], but also because of the potential
role of the gene products in inflammatory responses
associated with the development of OA [13,15,16,47,48].
Mostly, the previous association analyses have concen-
trated on the genes IL1A, IL1B and IL1RN and have left
the 470 kb region targeted in this study, with less atten-
tion. However, we did not see association in the pre-
viously more intensively studied area harbouring the
IL1A, IL1B and IL1RN genes using the Finnish hand
and knee OA materials.
The limited number of subjects with severe hand OA
(Table 1) is another limitation in this study. However, it
is important to emphasize the unique nature of this
study sample as its strength: the hand OA study sample
is based on the same material, which provided evidence
for linkage to this genome region on 2q in our genome
wide scan. Additionally, an association analysis with the
Pseudomarker program, which can utilize information
from several family members in addition to case-control
data, provided the strongest evidence for association.
Using the family based analysis putatively gives us the
advantage to identify population specific variants that
are important in understanding the aetiology of the dis-
ease. Further, most subjects in the hand OA material
have a severe end stage disease and very strict criteria
was used in selecting the study sample. Sequencing of
the associated region in these familial hand OA cases
may identify rare, potentially causative variant(s) of the
gene segregating with the common allelic variant in
these families. Thus, further validation in a large sample
set and additional biological evidence are required to
confirm the role of IL1R1 in severe hand OA.
A complex formed by IL-1, IL1R1 and IL1RAP initi-
ates numerous signalling pathways (see review [13]).
IL1R1 has three alternative promoters generating alter-
native transcripts [49]. The promoter region of IL1R1
has proven to be highly polymorphic, possibly due to
the polymorphisms affecting the degree of expression in
a wide variety of tissues [29]. IL1R1 is not abundant in
cells but less than 10 ligand-occupied receptor mole-
cules on the cell’s surface is enough to induce a strong
response due to parallel signalling pathways [50]. One of
these pathways leads to activation of NF-B, a regulator
of inflammatory and immune gene expression [15].
Lately, the contribution of NF-B signalling components
to the pathogenesis of different rheumatic diseases and
the pharmacologic modulation of NF-B has been
widely studied. These studies have yielded promising
results such as currently available therapeutic agents,
novel small molecule inhibitors and improved antisense
DNA therapy and RNA interference [51]. It has been
shown, that blocking the signal transduction of IL1R1
prevents OA progression in animal models [52]. This
would support the biological significance of our finding
of IL1R1 as a potential factor in OA development. All
four associated SNPs were located in the non-coding
region of IL1R1, but at least three of them (rs1465325,
rs3917225 and rs2287047) co-localized with predicted
transcription factor binding sites so that the conserved
allele matched with the consensus sequence of the tran-
scription factor binding site while the other allele did
not or changed it to other transcription factor binding
site (Computational Biology Research Center CBRC,
http://www.cbrc.jp/index.eng.html). Polymorphisms in
IL1R1 gene has been associated with other diseases as
well, for instance AIDS progression [53], endometriosis
[54] and Helicobacter pylori infection [55].
Conclusions
To summarize, a set of 32 SNPs mapping within a
470 kb region surrounding the strongest linkage peak of
a genome wide scan performed in Finnish severe hand
OA families was genotyped in 134 hand and 113 knee
OA cases and 436 controls. The family based association
analysis demonstrated association to four SNPs mapping
to a 125 kb DNA region comprising the IL1R1 gene.
The strongest evidence for association, observed with a
SNP rs2287047 located in the intron 1 of the IL1RL1
gene (p = 0.0009) remained significant after correction
for multiple testing. The haplotype analysis provided
further evidence for the IL1R1 gene: One haplotype
allele showed association with hand OA. The IL1R1
gene encodes receptor whose activation by the binding
of a specific ligand leads to activation of NF-B, which
is a modulator of inflammatory and immune gene
expression. However, the variants linked and associated
with hand OA in this study did not fully explain the ori-
ginal linkage observed in our previous study suggesting
that there may also be other hand OA predisposing var-
iants within this locus. Potentially chromosome region
2q harbors several variants in different genes affecting
the disease.
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